Nassau County Locations | NYU Langone Health
See all NYU Langone locations in Nassau County, Long Island, and find locations in your neighborhood.
NAUTIKA1: A Multicenter Phase II Neoadjuvant and Adjuvant Study of Multiple Therapies in Biomarker-Selected Patients with Resectable Stages IB-III Non-Small Cell Lung Cancer
Study ML41591, is an umbrella trial that will evaluate the efficacy and safety of targeted therapies in patients with resectable Stage IA2, IB, II, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) tumors harboring selected molecular alterations as determined in a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory.In this protocol, "study treatment" refers to treatments assigned to patients as part of this study, based on their molecular alterations (i.e., alectinib; entrectinib, and vemurafenib plus cobimetinib, given as a neoadjuvant and adjuvant treatment).
NCI Protocol #10612 A Randomized Phase 2 Study of Daratumumab-Selinexor-Velcade-Dexamethasone (Dara-SVD) for High-Risk Newly Diagnosed Multiple Myeloma
This is a Phase 2 study comparing whether the combination of study medicines daratumumab, selinexor, bortezomib, and dexamethasone is more effective than the standard medicine daratumumab, lenalidomide, bortezomib, and dexamethasone in patients newly diagnosed with high-risk multiple myeloma (HR MM). Patients will be randomly divided into two groups. Group 1 will receive the combination of four study medicines, namely daratumumab, selinexor, bortezomib, and dexamethasone. Group 2 will receive a combination of four standard-of-care medicines, namely daratumumab, lenalidomide, bortezomib, and dexamethasone. The study team will collect blood samples from all patients to see how their bodies are handling the medicines. Special scans will be taken for all patients to see how these medicines are changing their cancer. Study doctors will also collect bone marrow samples from all patients for special testing called minimum residual disease (MRD) testing to check for the presence of any cancer cells remaining in the body after treatment. All patients will be closely monitored for side effects and safety concerns.
Neck Pain | NYU Langone Health
NYU Langone specialists find the source of neck pain and manage it with medication, physical therapy, injections, and surgery.
Neonatal Comprehensive Care Program | NYU Langone Health
At the Neonatal Comprehensive Care Program, part of Hassenfeld Children’s Hospital at NYU Langone, we care for infants who have left the NICU.
Neonatal Intensive Care Unit at NYU Langone Hospital—Brooklyn | NYU Langone Health
The Neonatal Intensive Care Unit at NYU Langone Hospital—Brooklyn provides specialized care for babies born early or with low birth weight.
Neonatal Intensive Care Unit at NYU Langone Hospital—Long Island | NYU Langone Health
At the Neonatal Intensive Care Unit at NYU Langone Hospital—Long Island, we provide treatment for babies who need specialized care after birth.
Neonatal Intensive Care Unit at Tisch Hospital | NYU Langone Health
At the Neonatal Intensive Care Unit at Tisch Hospital, part of Hassenfeld Children’s Hospital at NYU Langone, we care for premature infants.
Neonatal Intensive Care Unit at Tisch Hospital Care Team | NYU Langone Health
Experts at Hassenfeld Children’s Hospital at NYU Langone provide the highest level of care for infants in the neonatal intensive care unit.
Nerve Block for Headache | NYU Langone Health
NYU Langone neurologists offer a procedure called a nerve block to stop the pain of an acute headache attack.